LPCN $10-$40Projected revenues for 2026 are 26,000% increase. June 2024 revenue Growth (YoY) 8630.55% After a negative growth 2023. With a wide range of drugs and applications the future seems promising.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.01 USD
8.35 K USD
11.20 M USD
5.19 M
About Lipocine Inc.
Sector
Industry
CEO
Mahesh V. Patel
Website
Headquarters
Salt Lake City
Founded
2011
FIGI
BBG0029L1X69
Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.
LPCN - Riding the Bullish WaveCurrent Price: $9.45
Date of Analysis: June 14th, 2024
Time Frame: Weekly
Chart Observations:
Moving Averages:
EMA 20 (Close): $5.62 - The stock is trading above the 20-week exponential moving average (EMA), indicating a bullish trend in the short term.
EMA 50 (Close): $4.68 - The stoc
$LPCN is gonna fall todayPupm&Dump trading strategy idea.
$LPCN is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $1,54;
stop-loss — $1,6;
take-profit — $1,42/MOC
Do not view
LPCN LongWeekly Chart
In Uptrend, sideway, near support
OBV > OBV40 ( in my OBV script, weekly chart uses 40 week)
Entry 1.3
Stop 1
Target 2.3
Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade o
Lipocine looks interestingJust a trading setup I'm monitoring on my watchlist no firm price target as of yet. There is cup with handle pattern that has been forming for months here. After forming the cup and getting rejected at 2.50 USD The stock has been trending down slowly and consolidating in a channel. A break of this
LPCN long set upNo investment advice!
I do this only for practicing.
I see a cup and handle
Very nice risk / reward here.
Upcoming Catalysts:
LPCN 1144
Non-alcoholic fatty liver disease (NAFLD) / Non-alcoholic steatohepatitis (NASH)
Phase 2
Mid-2021
Phase 2 top-line change in liver fat data met primary endpo
LPCN Entering at Support LevelPrice seems to have a lot of support around 1.80 , which looks like a nice point to enter. I would wait and see what this week holds, as I suspect it could go test that support again. I see this stock as a long-term play, but the price might oscillate around that support once more before rising.
I
How much is treatment fo Cirrhosis worth ?First i want to give a shout out to my research department for sliding this across my virtual desk. Jeff you the MAN .
1 in 400 adult in the USA has some form of Cirrhosis 1 in 400 Boomer has that shit . Comes in LPCN with a patented treatment of that deadly condition. Wait they are going to court
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of LPCN is 3.01 USD — it has decreased by −2.21% in the past 24 hours. Watch Lipocine Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lipocine Inc. stocks are traded under the ticker LPCN.
LPCN stock has fallen by −11.17% compared to the previous week, the month change is a 4.03% rise, over the last year Lipocine Inc. has showed a −38.19% decrease.
We've gathered analysts' opinions on Lipocine Inc. future price: according to them, LPCN price has a max estimate of 6.75 USD and a min estimate of 6.75 USD. Watch LPCN chart and read a more detailed Lipocine Inc. stock forecast: see what analysts think of Lipocine Inc. and suggest that you do with its stocks.
LPCN reached its all-time high on Aug 28, 2013 with the price of 340.14 USD, and its all-time low was 2.31 USD and was reached on Oct 30, 2023. View more price dynamics on LPCN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LPCN stock is 12.54% volatile and has beta coefficient of 0.49. Track Lipocine Inc. stock price on the chart and check out the list of the most volatile stocks — is Lipocine Inc. there?
Today Lipocine Inc. has the market capitalization of 16.59 M, it has decreased by −10.67% over the last week.
Yes, you can track Lipocine Inc. financials in yearly and quarterly reports right on TradingView.
Lipocine Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
LPCN earnings for the last quarter are 0.33 USD per share, whereas the estimation was −0.40 USD resulting in a 182.50% surprise. The estimated earnings for the next quarter are −0.35 USD per share. See more details about Lipocine Inc. earnings.
Lipocine Inc. revenue for the last quarter amounts to 3.49 M USD, despite the estimated figure of 2.61 M USD. In the next quarter, revenue is expected to reach 352.00 K USD.
LPCN net income for the last quarter is 1.78 M USD, while the quarter before that showed −2.22 M USD of net income which accounts for 180.32% change. Track more Lipocine Inc. financial stats to get the full picture.
No, LPCN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 4, 2025, the company has 16 employees. See our rating of the largest employees — is Lipocine Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lipocine Inc. EBITDA is −1.11 M USD, and current EBITDA margin is −9.95%. See more stats in Lipocine Inc. financial statements.
Like other stocks, LPCN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lipocine Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lipocine Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lipocine Inc. stock shows the sell signal. See more of Lipocine Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.